×
Adocia Long Term Debt 2016-2024 | ADOCY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Adocia long term debt from 2016 to 2024. Long term debt can be defined as the sum of all long term debt fields.
View More
Adocia Long Term Debt 2016-2024 | ADOCY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Adocia long term debt from 2016 to 2024. Long term debt can be defined as the sum of all long term debt fields.
Related Stocks
Company Name
Market
Cap
AstraZeneca (AZN)
$218.1B
Amgen (AMGN)
$157.3B
Gilead Sciences (GILD)
$135.7B
Vertex Pharmaceuticals (VRTX)
$119.2B
Bristol Myers Squibb (BMY)
$94.5B
CSL (CSLLY)
$78.8B
GSK (GSK)
$77.4B
Regeneron Pharmaceuticals (REGN)
$59.2B
Alnylam Pharmaceuticals (ALNY)
$40.6B
Argenex SE (ARGX)
$34B
BioNTech SE (BNTX)
$26.6B
Royalty Pharma (RPRX)
$20.5B
Insmed (INSM)
$19.5B
Biogen (BIIB)
$18.7B
Illumina (ILMN)
$15.4B
Genmab (GNMSF)
$14.2B
Genmab (GMAB)
$13.6B
Incyte (INCY)
$13.2B
Moderna (MRNA)
$12.2B
Exelixis (EXEL)
$12B
BioMarin Pharmaceutical (BMRN)
$10.9B
Ascendis Pharma (ASND)
$10.7B
QIAGEN (QGEN)
$10.5B
Swedish Orphan Biovitrum (BIOVF)
$10.4B
Exact Sciences (EXAS)
$10B
Verona Pharma American Depositary Share (VRNA)
$8.9B
Blueprint Medicines (BPMC)
$8.4B
Bio-Techne Corp (TECH)
$8.1B
Roivant Sciences (ROIV)
$7.7B
Legend Biotech (LEGN)
$7.3B